Day: February 18, 2020

HOUSTON, Feb. 18, 2020 (GLOBE NEWSWIRE) — Cardtronics, the world’s largest ATM operator, today announced that Amazon customers can now complete Amazon Cash transactions at more than 400 cash-accepting Cardtronics ATMs in the U.S. The ATMs, part of the Allpoint+ Network of surcharge-free deposit-taking ATMs for Allpoint members, operate card-free, allowing Amazon customers to add cash to their Amazon Balance to make future purchases on Amazon’s online store using only the phone number linked to their Amazon account with no added fees.Customers start by verifying their mobile phone number and identifying a participating Allpoint+ ATM location at amazon.com/amazoncash. Once at a participating location, the customer can add cash in any amount between $5 and $500 to their Amazon Balance by simply entering their mobile phone number; no...

Folsom, Feb. 18, 2020 (GLOBE NEWSWIRE) —                                                                                                 Media Contact:  Marissa Travaline(609) 561-9000 ext. 4227mtravaline@sjindustries.com                                                                                                          Investor Contact: Dan Fidell(609) 561-9000 ext. 7027dfidell@sjindustries.comFOR IMMEDIATE RELEASESJI Declares Quarterly DividendFOLSOM, NJ, February 18, 2020 – SJI’s (NYSE: SJI) board of directors declared its regular dividend of $0.29500 per share for the first quarter of 2020. The dividend is payable April 2, 2020 to shareholders of record at the close of business March 18, 2020. This is SJI’s 69th consecutive year of paying dividends, reflecting the company’s commitment to a consistent, sustainable dividend.About...

TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company focused on the research, development and commercialization of novel cannabinoid-based and life sciences products, is pleased to provide an update on the Company’s clinical development plan for Cannabidiol (“CBD”) in the treatment of Autoimmune Hepatitis (AIH).Revive is currently in the process of preparing its Investigational New Drug (“IND”) application for submission to the U.S. Food and Drug Administration (“FDA”) for CBD in the treatment of AIH.  The Company plans to submit the IND within ninety days with the objective to proceed with a proposed Phase 1/2a clinical study to determine the recommended dose of CBD for future clinical studies of AIH, to assess its safety, efficacy and clinical benefit, as well as to support...

PHOENIX, AZ, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — No Borders, Inc. (OTC: NBDR), announced today that actor and WWE Hall of Fame Wrestler Kevin Nash has joined its subsidiary No Borders Naturals® as a Global Brand Ambassador and Company Spokesperson to help spread awareness about the benefits that hemp cannabidiol (CBD) provides for athletes and active consumers. “Kevin is exactly the type of person that we are looking to partner with on our No Borders Naturals journey,” said No Borders Naturals CEO Joseph Snyder. “He not only has the values and family centric ideals that we hold dear but he has spent a vibrant life taking (quite literally) a beating and coming out on top smiling!”Kevin Scott Nash is a retired Detroit-born American actor and former professional wrestler, best known for his tenures...

The Company has finalized the formulation blueprint for its proposed Pharmaceutical Grade Version of Tauri-Gum™NEW YORK, NY, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today reported meaningful progress in the development of its pharmaceutical grade version of Tauri-Gum™.  On January 13, 2020, the Company announced the formation of a wholly owned subsidiary, “Tauriga Pharma Corporation,” to reflect the ongoing development of a pharmaceutical Nausea Regulation (“Anti-Nausea”) product.  The Company has finalized the formulation for this proposed...

ROCHESTER, Mich., Feb. 18, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has launched its first health technology solution from OptimizeRx Innovation Lab, aimed at increasing speed to therapy for patients by providing timely access to enrollment forms within the provider workflow, making it easier for patients to enroll in specialty drug support programs provided by hub services.Part of the OptimizeRx platform, the new hub-enrollment solution improves patient access to specialty medications in two ways: First, it alerts healthcare providers that the chosen drug must be filled at a specialty pharmacy – at the time that the provider is writing the script in the electronic health record (EHR). Second, the solution automatically surfaces...

Bestyrelsen for Investeringsforeningen Multi Manager Invest har i dag behandlet og godkendt foreningens årsrapport for 2019.Foreningen oplevede afkastmæssigt et godt år i 2019. Alle afdelinger leverede positive afkast, der var væsentligt højere end ledelsens forventninger primo året.Samtlige afdelingers afkast var højere end afdelingernes respektive benchmark. Ledelsen finder afkastudviklingen i foreningens afdelinger tilfredsstillende.For det kommende år skønner ledelsen moderat positive afkast for foreningens afdelinger. Afkastene i 2020 må forventes at blive markant lavere end de afkast, der blev opnået i 2019. Væsentlige afkastudsving i foreningens afdelinger må forventes, og negative afkast kan ikke udelukkes i 2020.Eventuel henvendelse vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted, tlf. 44 55 92 00.Med venlig...

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that Ron Rocca, CEO of Exagen, will present at the Cowen and Company 40th Annual Healthcare Conference on Monday, March 2, 2020 in Boston.  Mr. Rocca’s presentation will take place at 3:30 p.m. EST. A link to the live webcast of the presentation will be available online from the investor relations section of the Exagen website at https://investors.exagen.com/A replay of the webcast will be accessible on the Exagen investor relations website beginning approximately one hour following the completion of the event.About Exagen Inc.Exagen...

VANCOUVER, Colombie-Britannique, Feb. 18, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) (OTCPK : AGFAF) une société internationale de cannabis diversifiée et axée sur la croissance est heureuse d’annoncer que la filiale à part entière de la société, Farmako GmbH (« Farmako ») continue de se positionner comme un grossiste pharmaceutique compétitif en vue d’assurer un accès durable aux produits à base de cannabis médical pour les patients sur le marché allemand. Le 13 février 2020, Farmako a reçu une autorisation spéciale du Federal Institute for Drugs and Medical Devices (« BfArm ») pour la distribution de fleurs de cannabis médical, qui ont subi un traitement par irradiation (la « licence AMRadV »).La licence AMRadV est obligatoire en Allemagne pour...

LYON, France, February 18, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company recently showcased its Focal One high intensity focused ultrasound (HIFU) device at the 12th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, which was held February 9-11 in Washington, DC. This marks the first time that the symposium was held in the U.S. since FDA clearance of Focal One in June 2018.  “We are pleased to have been featured in this very prestigious and highly specialized symposium on focal imaging and therapy that attracts urology thought leaders from around the world,” said Marc Oczachowski, Chief Executive Officer of EDAP. “This annual gathering is the most important and referenced event for focal therapy in urology disorders,...